
    
      CDX-0159 is a humanized monoclonal antibody that binds to a protein called KIT that is
      expressed on mast cells.

      This study will evaluate the safety, pharmacokinetics, and pharmacodynamics of CDX-0159 in
      healthy subjects.
    
  